Yan-e Du

700 citations

13 papers · 582 indexed · h-index 9

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Immunology and Allergy top 10%

Papers in ⓘ

Cancer Research 9
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 2
Molecular Biology 12
- Circular RNAs in diseases 3
- Extracellular vesicles in disease 2

Co-authors: Manran Liu (9 shared papers)Yixuan Hou (7 shared papers)Siyang Wen (8 shared papers)Xi Tang (6 shared papers)Liyun Xu (6 shared papers)Mingli Zhou (4 shared papers)Hailong Zhang (5 shared papers)Gang Tu (4 shared papers)
Journals: Stem Cells (1 paper)Talanta (1 paper)Cell Cycle (1 paper)Digestive Diseases and Sciences (1 paper)Biomedicine & Pharmacotherapy (1 paper)
Partner nations: China United States Thailand

In The Last Decade

Yan-e Du

13 papers receiving 579 citations

Peers

Countries citing papers authored by Yan-e Du

Since Specialization

Citations

This map shows the geographic impact of Yan-e Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan-e Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan-e Du more than expected).

Fields of papers citing papers by Yan-e Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan-e Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan-e Du. The network helps show where Yan-e Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Yan-e Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yan-e Du Line = papers co-authored together Yan-e Du links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway Stem Cells ·Mingli Zhou, Yixuan Hou, Guanglun Yang, Hailong Zhang, Gang Tu, Yan-e Du, Siyang Wen, Liyun Xu, Xi Tang, Shifu Tang, Yang Li, Xiaojiang Cui, Manran Liu	2015	145
2	Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways Oncotarget ·Li Yang, Yixuan Hou, Jie Yuan, Shifu Tang, Hailong Zhang, Qing Zhu, Yan-e Du, Mingli Zhou, Siyang Wen, Liyun Xu, Xi Tang, Xiaojiang Cui, Manran Liu	2015	99
3	MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling Theranostics ·Yan-e Du, Gang Tu, Guanglun Yang, Genyou Li, Dan Yang, Lei Lang, Lei Xi, Kexin Sun, Yanlin Chen, Kunxian Shu, Huadong Liao, Manran Liu, Yixuan Hou	2017	89
4	Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network The International Journal of Biochemistry & Cell Biology ·Jiajia Yang, Yixuan Hou, Mingli Zhou, Siyang Wen, Jian Zhou, Liyun Xu, Xi Tang, Yan-e Du, Ping Hu, Manran Liu	2015	83
5	Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer Cell Death and Disease ·Liyun Xu, Yixuan Hou, Gang Tu, Yanlin Chen, Yan-e Du, Hailong Zhang, Siyang Wen, Xi Tang, Jiali Yin, Lei Lang, Kexin Sun, Guanglun Yang, Xiaoli Tang, Manran Liu	2017	64
6	Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-β-catenin signaling pathways Cell Cycle ·Shifu Tang, Yixuan Hou, Hailong Zhang, Gang Tu, Li Yang, Yifan Sun, Lei Lang, Xi Tang, Yan-e Du, Mingli Zhou, Tenghua Yu, Liyun Xu, Siyang Wen, Chunming Liu, Manran Liu	2015	39
7	Serum MicroRNA-21 as a Diagnostic Marker for Lung Carcinoma: A Systematic Review and Meta-Analysis PLoS ONE ·Xiaorong Yang, Yanan Guo, Yan-e Du, Jinmei Yang, Shichao Li, Shengnan Liu, Ke Li, Dechun Zhang	2014	30
8	Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients Digestive Diseases and Sciences ·Hailong Zhang, Yixuan Hou, Liyun Xu, Zongyue Zeng, Siyang Wen, Yan-e Du, Kexin Sun, Jiali Yin, Lei Lang, Xiaoli Tang, Manran Liu	2015	9
9	TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yuxiang Qiu, Xing Wang, Yan Sun, Yan-e Du, Guobing Yin, Haojun Luo, Siyang Wen, Lei Lang, Manran Liu, Xi Tang	2023	8
10	A novel combined therapeutic strategy of Nano-EN-IR@Lip mediated photothermal therapy and stem cell inhibition for gastric cancer Biomedicine & Pharmacotherapy ·Liping Yang, Yan-e Du, Fangli Liao, Tong Huang, Yadong Liu, Junzhao Liu, Can Wang, Zhu Zhan, Yang Cao, Zhigang Wang, Weixian Chen	2024	6
11	Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis Disease Markers ·Ying-Wen Liu, Jing Shi, Bo Wang, Lijing Zhou, Xiaolan Zhou, Yan-e Du, Dandan Li, Liang Duan, Qin Hu, Weixian Chen, Pu Li	2021	4
12	[Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts]. PubMed ·Zongyue Zeng, Ping Hu, Xi Tang, Hailong Zhang, Yan-e Du, Siyang Wen, Manran Liu	2014	4
13	DNA nanoframework-confined well-organized catalytic hairpin assembly for highly sensitive and specific detection of MiRNA Talanta ·Yongbin Hou, Yong Huang, Yan-e Du, Bo Shen, Zongying Li, Mai Li, Yunting Zhang, Dandan Li, Weixian Chen	2025	2

About Yan-e Du

Yan-e Du is a scholar working on Cancer Research, Molecular Biology, Oncology, Cell Biology and Rheumatology, having authored 13 papers that have together received 582 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Extracellular vesicles in disease (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (323 citations), Immunology and Allergy (42 citations), Oncology (171 citations), Molecular Biology (428 citations) and Cell Biology (58 citations). Yan-e Du has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Manran Liu, Yixuan Hou, Siyang Wen, Xi Tang, Liyun Xu, Mingli Zhou, Hailong Zhang, Gang Tu, Guanglun Yang and Shifu Tang. Their work appears in journals such as Stem Cells, Talanta, Cell Cycle, Digestive Diseases and Sciences and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact